Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00024
Species: Homo sapiens
Position : chr12:4900187-4901013
Year: 2025
Title: Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  40729681
MONDO: MONDO:0004945
Tissue: Bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: RS4;11
CVCL ID: CVCL_0093
Cell Type: B-ALL blast cell
Cell Ontology ID: CL:0000692
Experiment Type: CRISPR-Cas9 deletion loss-of-function, Capture-C chromatin interaction, ChIP-qPCR
High Throughput Method: ATAC-seq, H3K27ac CUT&Tag, ChIP-seq, RNA-seq, Micro-Capture-C
Low Throughput Method: WGS, RT-qPCR, CRISPR editing, cell transfection
About Target Gene
Target gene : ARID1B
About TF
TF name : AFF1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_00023 chr12:4900187-4901013 Bone marrow B-ALL blast cell B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer